MetaCap

Veraxa Biotech Statistics

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04+0.01 (+0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Veraxa Biotech by the numbers

Veraxa Biotech has a market capitalization of $147.1 million based on 141.41M shares outstanding. With trailing EPS of $-0.57, Veraxa Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 83.3% below its 200-day average.

Average daily trading volume is 267.82K shares, or about $278,530 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VRXA valuation vs. peer median

VRXA compared with the median of 8 peer companies
MetricVRXAPeer medianDifference
Market cap$147.06M$148.13M-1%
Avg. volume267.82K831.15K-68%

Peer median across 8 companies: BBOT, PRQR, RNA, ELDN, IFRX, ALXO, ORMP, ZNTL.

Valuation

Price and trading

Previous close
1.03
Open
1.03
Day range
1.03 – 1.06
52-week range
0.90 – 27.36
52-week change
-90.10%
Beta
—
Volume
114.63K

Dividends and events

Additional statistics

Market Cap
147.06M
Eps
-0.57
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
27.36
Week52 Low
0.90
Avg Volume
267.82K
Shares Outstanding
141.41M
Ma50
1.17
Ma200
6.25
Pct From52w High
-96.20%
Pct From52w Low
15.56%

Related